Co-Diagnostics (CODX) Liabilities and Shareholders Equity (2016 - 2026)
Co-Diagnostics (CODX) reported Liabilities and Shareholders Equity of $16.59 million for Q2 2026, down 64.3% from $46.47 million a year earlier.
Powered by 
Analysis
Co-Diagnostics (CODX) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends
At the end of FY2025, Co-Diagnostics posted Liabilities and Shareholders Equity of $24.74 million, down 61.1% from FY2024.
- Liabilities and Shareholders Equity has declined for four consecutive years, with a five-year compound annual growth rate of -19.1% (FY2020 to FY2025).
- By year, Liabilities and Shareholders Equity came in at $63.56 million in FY2024 (-33.3%), $95.32 million in FY2023 (-22.6%), $123.09 million in FY2022 (-23.1%) and $160.03 million in FY2021 (+124.6%).
- The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity since Q4 2019.
- The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2021 (growth of 124.6%); the low point was Q2 2026 (a decline of 64.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 247.46 Bn | 226.49 Bn | 4.88 Bn | 113.17 Bn |
| 2 | Abbott Laboratories | 177.97 Bn | 148.40 Bn | 7.27 Bn | 109.22 Bn |
| 3 | Danaher | 159.52 Bn | 143.33 Bn | 3.61 Bn | 92.37 Bn |
| 4 | Intuitive Surgical | 157.82 Bn | 138.11 Bn | 2.08 Bn | 19.35 Bn |
| 5 | Medtronic | 122.28 Bn | 87.53 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 117.64 Bn | 103.76 Bn | 4.50 Bn | 47.93 Bn |
| 7 | Boston Scientific | 66.58 Bn | 61.35 Bn | 3.85 Bn | 45.22 Bn |
| 8 | Becton Dickinson | 54.22 Bn | 51.37 Bn | 2.32 Bn | 50.73 Bn |
| 9 | Edwards Lifesciences | 51.47 Bn | 35.47 Bn | 1.35 Bn | 13.87 Bn |
| 10 | Co-Diagnostics | 2.37 Mn | -37.97 Mn | 120,828.00 | 16.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.59 Mn |
| Dec 31, 2025 | 24.74 Mn |
| Sep 30, 2025 | 44.74 Mn |
| Jun 30, 2025 | 46.47 Mn |
| Mar 31, 2025 | 55.15 Mn |
| Dec 31, 2024 | 63.56 Mn |
| Sep 30, 2024 | 72.38 Mn |
| Jun 30, 2024 | 80.70 Mn |
| Mar 31, 2024 | 86.67 Mn |
| Dec 31, 2023 | 95.32 Mn |
| Sep 30, 2023 | 108.68 Mn |
| Jun 30, 2023 | 112.80 Mn |
| Mar 31, 2023 | 117.00 Mn |
| Dec 31, 2022 | 123.09 Mn |
| Sep 30, 2022 | 147.84 Mn |
| Jun 30, 2022 | 160.84 Mn |
| Mar 31, 2022 | 171.15 Mn |
| Dec 31, 2021 | 160.03 Mn |
| Sep 30, 2021 | 105.36 Mn |
| Jun 30, 2021 | 92.79 Mn |
API Access
Co-Diagnostics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CODX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "CODX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=CODX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();